Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.03M Sell
56,400
-184,100
-77% -$20.3M ﹤0.01% 2806
2026
Q1
$1.37B Sell
240,500
-183,000
-43% -$21.5M 0.57% 19
2025
Q4
$52.9M Buy
423,500
+418,600
+8,543% +$49.9M 0.02% 784
2025
Q3
$588K Buy
+4,900
New +$517K ﹤0.01% 4970
2025
Q2
Sell
-100,200
Closed -$671M 5922
2025
Q1
$671M Buy
+100,200
New +$9.85M 0.36% 31
2024
Q3
Sell
-125,000
Closed -$9.37M 6150
2024
Q2
$9.37M Buy
+125,000
New +$9.97M ﹤0.01% 2143

Other funds holding CRH

Israel Englander's CRH Position: Q2 2026 in Review

Israel Englander reduced its CRH (CRH) stake by 30% in Q2 2026, selling an estimated $60M and leaving 1,271,475 shares worth $136M. The position accounts for 0.05% of the portfolio, ranked #382.

Israel Englander first reported a position in CRH in Q2 2013 and has held it in 41 quarters since. The position peaked at $1.11B in Q1 2024. 1,023 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Israel Englander held 1,271,475 shares of CRH worth $136M as of Q2 2026.
  • Israel Englander sold 545,415 CRH shares in Q2 2026, an estimated $60M.
  • CRH made up 0.05% of Israel Englander's portfolio in Q2 2026, its #382 holding.
  • Israel Englander first reported a position in CRH in Q2 2013 and has held it in 41 quarters since.
  • Israel Englander's CRH position peaked at $1.11B in Q1 2024.
  • 1,023 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.